COVID-19 Investigational Drugs and Supply Chain

After hearing about shortages of investigational drugs for COVID-19, I’ve pulled the relevant information to help drug manufacturers, suppliers, distributors, and pharmacies to track and source drugs with potential efficacy against COVID-19.

CAUTION: This material is for informational purposes only. Listing on this page does not imply that these compounds have been evaluated by any government agency, or should be used, for any purpose. If you are a patient seeking guidance, contact a health professional.

Please let me know what more I can do.

Comments are closed.